Japan's SSP Subject Of $335 Million Tender Offer By Boehringer Ingelheim
This article was originally published in PharmAsia News
Executive Summary
SSP of Japan apparently is about to be acquired by Boehringer Ingelheim and turned into a wholly owned subsidiary